ContractEmployment Agreement • November 2nd, 2017 • Hoverink Biotechnologies, Inc. • Pharmaceutical preparations • Delaware
EMPLOYMENT AGREEMENT (this “ Agreement ”), dated as of ___________________, by and between Hoverink Biotechnologies, Inc.., a Delaware corporation (the “ Company ”), and Davidra Sajna. (the “ Executive ”).
HOVERINK BIOTECHNOLOGIES, INC. RESTRICTED STOCK GRANT AGREEMENTRestricted Stock Grant Agreement • November 2nd, 2017 • Hoverink Biotechnologies, Inc. • Pharmaceutical preparations • Delaware
WHEREAS, the Board of Hoverink Biotechnologies, Inc., a Delaware Corporation (the “Company”), has determined that the grant of Restricted shares of the Company’s Common Stock to Davidra Sajna, (the “Chairman Of The Board”) in recognition and appreciation of services previously performed by the Chairman Of The Board on behalf of the Company is an effective means to align management interest with stockholder interests;
HOVERINK BIOTECHNOLOGIES, INC. RESTRICTED STOCK GRANT AGREEMENTRestricted Stock Grant Agreement • November 2nd, 2017 • Hoverink Biotechnologies, Inc. • Pharmaceutical preparations • Delaware
WHEREAS, the Board of Hoverink Biotechnologies, Inc., a Delaware Corporation (the “Company”), has determined that the grant of Restricted shares of the Company’s Common Stock to Debbie Mae Carter , (the “Chief Executive Officer”) in recognition and appreciation of services previously performed by the Chief Executive Officer on behalf of the Company is an effective means to align management interest with stockholder interests;
LOAN (Principal and Interest at Maturity)Loan Agreement • September 25th, 2017 • Hoverink Biotechnologies, Inc. • Blank checks
In consideration of value received, the undersigned (hereinafter "Hoverink Biotechnologies, Inc. Borrower") does hereby promise to pay to w. Cyrus Sajna (hereinafter "Lender"), the amount of $115,060 upon which interest will accrue at 0 percent per annum. Borrower agrees to pay all accrued interest plus principal on the 22nd day of Sept 2022. Any payments shall be first applied to interest and then to the principal. This loan may be paid in full at any time without penalty charges.
HOVERINK BIOTECHNOLOGIES, INC. RESTRICTED STOCK GRANT AGREEMENTRestricted Stock Grant Agreement • September 28th, 2017 • Hoverink Biotechnologies, Inc. • Blank checks • Delaware
WHEREAS, the Board of Hoverink Biotechnologies, Inc., a Delaware Corporation (the “Company”), has determined that the grant of Restricted shares of the Company’s Common Stock to Cyrus Sajna , (the “Vice President”) in recognition and appreciation of services previously performed by the Vice President on behalf of the Company is an effective means to align management interest with stockholder interests;
HOVERINK BIOTECHNOLOGIES, INC. RESTRICTED STOCK GRANT AGREEMENTRestricted Stock Grant Agreement • November 2nd, 2017 • Hoverink Biotechnologies, Inc. • Pharmaceutical preparations • Delaware
WHEREAS, the Board of Hoverink Biotechnologies, Inc., a Delaware Corporation (the “Company”), has determined that the grant of Restricted shares of the Company’s Common Stock to W. Neil Gallagher, (the “Consultant”) in recognition and appreciation of services previously performed by W. Neil Gallagher, (the “Consultant”) on behalf of the Company is an effective means to align management interest with stockholder interests;
DRAFT- Letter of IntentLetter of Intent • February 15th, 2017 • Hoverink International Holdings Inc. • Blank checks
Smt Investors LLP, An and Dc Irrevocable Trust; San Isidro Six Investments LLC, Scm-Neal LLLP (“Seller”) agrees to sell the Property, defined below to Hoverink International Holdings, Inc. ("Purchaser”) on the following terms and conditions:
HOVERINK BIOTECHNOLOGIES, INC. RESTRICTED STOCK GRANT AGREEMENTRestricted Stock Grant Agreement • September 28th, 2017 • Hoverink Biotechnologies, Inc. • Blank checks • Delaware
WHEREAS, the Board of Hoverink Biotechnologies, Inc., a Delaware Corporation (the “Company”), has determined that the grant of Restricted shares of the Company’s Common Stock to Debbie Mae Carter , (the “Chief Executive Officer”) in recognition and appreciation of services previously performed by the Chief Executive Officer on behalf of the Company is an effective means to align management interest with stockholder interests;
LOANLoan Agreement • December 28th, 2017 • Hoverink Biotechnologies, Inc. • Pharmaceutical preparations
In consideration of value received, the undersigned (hereinafter "Hoverink Biotechnologies, Inc. Borrower") does hereby promise to pay to Cyrus Sajna (hereinafter "Lender"), the amount of $13,020 upon which interest will accrue at 0 percent per annum. Borrower agrees to pay all accrued interest plus principal on the 1ST day of DEC 2022. Any payments shall be first applied to interest and then to the principal. This loan may be paid in full at any time without penalty charges.
HOVERINK BIOTECHNOLOGIES, INC. RESTRICTED STOCK GRANT AGREEMENTRestricted Stock Grant Agreement • November 2nd, 2017 • Hoverink Biotechnologies, Inc. • Pharmaceutical preparations • Delaware
WHEREAS, the Board of Hoverink Biotechnologies, Inc., a Delaware Corporation (the “Company”), has determined that the grant of Restricted shares of the Company’s Common Stock to Cyrus Sajna , (the “Vice President”) in recognition and appreciation of services previously performed by the Vice President on behalf of the Company is an effective means to align management interest with stockholder interests;
CONSULTING AGREEMENTConsulting Agreement • November 2nd, 2017 • Hoverink Biotechnologies, Inc. • Pharmaceutical preparations • Texas
THIS CONSULTING AGREEMENT (“Agreement”) is entered into this ___th day of September 2017, by and between Hoverink, an Corporation organized under the laws of the State of Delaware, (hereinafter referred to as the "Company"), and W. Neil Gallagher, an independent contractor whose address is 1845 Precinct Line Rd # 215, Hurst, TX 76054 (the "Consultant”).
LOAN (Principal and Interest at Maturity)Loan Agreement • November 2nd, 2017 • Hoverink Biotechnologies, Inc. • Pharmaceutical preparations
In consideration of value received, the undersigned (hereinafter "Hoverink Biotechnologies, Inc. Borrower") does hereby promise to pay to w. Cyrus Sajna (hereinafter "Lender"), the amount of $_115,060_____ upon which interest will accrue at _0__ percent per annum. Borrower agrees to pay all accrued interest plus principal on the _22nd_ day of __Sept___ 2022_. Any payments shall be first applied to interest and then to the principal. This loan may be paid in full at any time without penalty charges.
